GlassScriptPhysician profile
Nancy M Richards
NPI 1437514882
$8,713.19
in general payments reported to CMS, 2019-2025
11 companies · $859 in 2025
The $859 reported for 2025 was more than what 86% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,650 · 2022: $453 · 2023: $1,216 · 2024: $4,535 · 2025: $859.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,513 · Travel and Lodging: $1,720 · Consulting Fee: $1,350 · Entertainment: $26.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,513.16 |
| Travel and Lodging | $1,720.40 |
| Consulting Fee | $1,350.00 |
| Entertainment | $26.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,020.73 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, 2nd Gen Centrimag Primary Console |
| Medtronic, INC. | $3,019.65 | 2021-2025 | Hvad Pump Implant Kit |
| Novo Nordisk INC | $190.28 | 2022-2025 | Wegovy |
| Cvrx, INC. | $142.75 | 2024 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.00 | 2021 | |
| Boston Scientific Corporation | $86.65 | 2022-2024 | Watchman Flx |
| Nxstage Medical, INC. | $55.04 | 2023 | Nxstage System One |
| Novartis Pharmaceuticals Corporation | $38.93 | 2021-2023 | |
| Argentum Medical | $26.02 | 2025 | |
| Merck Sharp & Dohme LLC | $19.02 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.